Discovery, Integration, Innovation

Palace Therapeutics is a biotechnology company founded in 2018 to build next-generation biologic medicines for treating cancers and cardiovascular diseases. Since our inception, we’ve focused on translating rigorous molecular and cellular research into therapeutic programs designed to develop solutions to complex, high-impact problems that conventional approaches may not provide.

Our scientific foundation utilizes an efficient and flexible technology platform to develop mRNA therapeutics and other advanced biologic modalities. By integrating these platforms under one development engine, we’re able to move from target discovery to optimized candidates with speed and intent—combining deep technical expertise with a practical focus on safety, efficacy, and scalable development.